Evidence map›Paper›PMID 36035353›Full record

ReviewAsian journal of urology2022

Small renal masses in kidney transplantation: Overview of clinical impact and management in donors and recipients.

Alberto Piana, Iulia Andras, Pietro Diana, Paolo Verri, Andrea Gallioli, Riccardo Campi, Thomas Prudhomme, Vital Hevia, Romain Boissier, Alberto Breda and 2 more

Abstract readReview
In one paragraph

Review in Asian journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alberto PianaDepartment of Urology, Fundació Puigvert, Autonoma University of Barcelona, Spain.
Iulia AndrasUrology Department, Iuliu Hatieganu University of Medicine and Pharmacy and Municipal Hospital, Cluj-Napoca, Romania.
Pietro DianaDepartment of Urology, Fundació Puigvert, Autonoma University of Barcelona, Spain.
Paolo VerriDepartment of Urology, Fundació Puigvert, Autonoma University of Barcelona, Spain.
Andrea GallioliDepartment of Urology, Fundació Puigvert, Autonoma University of Barcelona, Spain.
Riccardo CampiUnit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy.
Thomas PrudhommeDepartment of Urology and Kidney Transplantation, Toulouse University Hospital, Toulouse, France.
Vital HeviaHospital Universitario Ramon y Cajal. Alcala University, Instituto Ramon y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Romain BoissierAix-Marseille université, service de chirurgie urologique et de transplantation rénale, CHU Conception, AP-HM, Marseille, France.
Alberto BredaDepartment of Urology, Fundació Puigvert, Autonoma University of Barcelona, Spain.
Angelo TerritoDepartment of Urology, Fundació Puigvert, Autonoma University of Barcelona, Spain.
European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Transplantation Working Group, Arnhem, Netherlands

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney transplantation is the best replacement treatment for the end-stage renal disease. Currently, the imbalance between the number of patients on a transplant list and the number of organs available constitutes the crucial limitation of this approach. To expand the pool of organs amenable for transplantation, kidneys coming from older patients have been employed; however, the combination of these organs in conjunction with the chronic use of immunosuppressive therapy increases the risk of incidence of graft small renal tumors. This narrative review aims to provide the state of the art on the clinical impact and management of incidentally diagnosed small renal tumors in either donors or recipients. According to the most updated evidence, the use of grafts with a small renal mass, after bench table tumor excision, may be considered a safe option for high-risk patients in hemodialysis. On the other hand, an early small renal mass finding on periodic ultrasound-evaluation in the graft should allow to perform a conservative treatment in order to preserve renal function. Finally, in case of a renal tumor in native kidney, a radical nephrectomy is usually recommended.

Indexed as

Kidney transplantationNephron-sparing treatmentRenal cancerSmall renal mass

Identifiers

PMID36035353
PMCPMC9399547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.